SUPERLUMINAL MEDICINES Trademark

Trademark Overview


On Friday, October 6, 2023, a trademark application was filed for SUPERLUMINAL MEDICINES with the United States Patent and Trademark Office. The USPTO has given the SUPERLUMINAL MEDICINES trademark a serial number of 98212701. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, September 3, 2024. This trademark is owned by Superluminal Medicines, Inc.. The SUPERLUMINAL MEDICINES trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical agents modulating high value protein targets such as G protein coupled receptors

Development of pharmaceutical preparations and medicines
superluminal medicines

General Information


Serial Number98212701
Word MarkSUPERLUMINAL MEDICINES
Filing DateFriday, October 6, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, September 3, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 9, 2024

Trademark Statements


Goods and ServicesPharmaceutical agents modulating high value protein targets such as G protein coupled receptors
NOT AVAILABLE"MEDICINES"
Goods and ServicesDevelopment of pharmaceutical preparations and medicines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, October 14, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, October 14, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSuperluminal Medicines, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02116

Party NameSuperluminal Medicines, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02116

Trademark Events


Event DateEvent Description
Tuesday, October 10, 2023NEW APPLICATION ENTERED
Saturday, October 14, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 4, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 4, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, June 4, 2024EXAMINERS AMENDMENT -WRITTEN
Tuesday, June 4, 2024EXAMINER'S AMENDMENT ENTERED
Tuesday, June 4, 2024EXAMINERS AMENDMENT E-MAILED
Wednesday, June 19, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 9, 2024PUBLISHED FOR OPPOSITION
Tuesday, July 9, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 3, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 28, 2024ASSIGNED TO EXAMINER